Fritextsökning
Innehållstyper
-
Investment CEO: “The Nordics are outstanding in creating successful medtech companies”
in, which companies she believes in the most in the portfolio and why she accepted the new position.
-
KI-studie: Blodprov kan förutspå och utesluta framtida demens
Förekomsten av vissa biomarkörer i blodet kan förutsäga utvecklingen av demens upp tio år innan en faktisk diagnos ställs, enligt en ny studie vid Karolinska institutet.
-
Seminarier får svensk life science att blomstra: “Fyller rummet med rätt personer”
Minimala risker, maximal räckvidd. Genom ett unikt koncept hjälper nu Medicon Valley Alliance företag att skapa mötesplatser där rätt personer samlas – och intresset ökar.
-
Ånga är en ren och hållbar energikälla
Ånga är en ren och hållbar energikälla. Den är lätt att distribuera och när den har gjort sitt jobb är den bara vatten, vilket är betryggande i vår miljömedvetna värld.
-
From powder to implant
Quality assurance for additively manufactured implants.
-
Pneumatics Makes a Technological Leap with Piezo
The first high-precision proportional valve terminal VTEP opens up new application areas
-
Roche’s Genentech terminates licencing deal with Norwegian biotech
Genentech is ending a license collaboration with Norwegian biotech Nykode Therapeutics regarding a clinical stage cancer vaccine program.
-
Quality Assurance for the Highest Medical Standards
Metrology Solutions for Medical Components.
-
Astra Zeneca’s Sweden CEO: “We have great faith in our portfolio”
It all started with a summer job as an operator at Astra’s chemical factory in Snäckviken, just outside Södertälje. More than three decades and countless differ...
-
Drug development booms in Medicon Valley
When it comes to developing new medicines, the Öresund region is one of the top performers in the EU. Companies working on commission for pharmaceutical compani...
-
Improve your secondary battery manufacturing
SMC provides a large portfolio of products specially designed for secondary battery industry.
-
Japanese pharma to buy US drugmaker for $2.4 bln
Japanese Ono Pharmaceutical buys the American cancer drug developer Deciphera Pharmaceuticals in one of the largest acquisitions in the industry so far this year.
-
Danish biotech to buy struggling American oncology company
Danish drugmaker Pharmacosmos has agreed to acquire American pharmaceutical company G1 Therapeutics in a deal that amounts to 405 million dollars.
-
How to transport hydrogen - the BionicHydrogenBattery
Have you ever wondered how hydrogen should be transported and stored safely. Well, here is a solution for all who is interested in making a true infrastructure work.
-
Superconductor technology: Contactless working in the laboratory of the future
Automated filling and weighing of freeze-dry containers in the cleanroom with SupraMotion from Festo
-
Scientific Solutions
-
Sustainability at Festo
On the Way to the Net Zero Era - New Sustainability Report published
-
Rise and Scantox cease conducting animal testing in Stockholm
Access to in vivo toxicology services is significantly decreasing in the Stockholm area as Rise shuts down animal testing and Scantox reorganizes. ”The costs ar...
-
Eli Lilly to build a USD 2.5-billion plant in Germany
US-based Eli Lilly is planning a huge investment of USD 2.5 billion, equivalent to around SEK 26.5 billion, in a new production facility in Alzey, Germany.
-
Minimal internvolym ger stora fördelar i ny ventil
Med LVM07 bygger SMC ut LVM-serien av 2- och 3-portsventiler för kemikalier till att omfatta fem storlekar med genomlopp från 0,8 till 2 mm.
-
Tailings – från slam till pasta
Tyska ABEL GmbH är experter på att pumpa slitande och aggressiva medier i extrema förhållanden.
-
Tailings - från slam till pasta
Tyska ABEL GmbH är experter på att pumpa slitande och aggressiva medier i extrema förhållanden.
-
Bioarctic granted Japanese patent for Parkinson’s disease candidate
Bioarctic has been granted a Japanese patent for its antibodies targeting Parkinson’s disease.
-
Novo Nordisk invests billions in expanding its production capacity
Danish pharmaceutical company Novo Nordisk is making a major investment to develop and expand its production facility in Hillerød, north of Copenhagen. DKK 15.9...